Fundraising Fox

Recodetx

10 known investors

recodetx.com ↗

ReCode develops mRNA and gene correction therapeutics for genetic diseases, using proprietary lipid nanoparticle technology to deliver treatments to specific organs. The company is focused on rare genetic conditions including cystic fibrosis and primary ciliary dyskinesia.

AI & Machine LearningBiotechMedical Devicesin /recode-therapeutics

Founders & leadership

DD

Dr. Daniel J. Siegwart

Investors · 10

Aju IB Invesment CorporationSeoul

EcoR1 CapitalSan Francisco

Evolution VC PartnersNew York

MPM BioImpactBoston · $1M – $15M

OrbiMedNew York · $1M – $75M

Pfizer Venture Investments$5M – $20M

Sanofi VenturesCambridge · $5M

Solasta VenturesBoston

Vida VenturesLos Angeles

In the news

Venture funding drops in Seattle area as AI boom reshapes startup world – GeekWiregeekwire.com · 2026
Seeds | Jumps to World Model Unicorn in One Year! Manifold AI Raises Hundreds of Millions in New Funding | Gasgooautonews.gasgoo.com · 2026
Fei-Fei Li's World Labs Raises $1B in Fresh Funding to Advance Development of World Modelstheaiinsider.tech · 2026